ABVC BioPharma, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABVC BioPharma, Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $528.18K.
- ABVC BioPharma, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $738.37K.
- ABVC BioPharma, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $2.04M.
- ABVC BioPharma, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $411.67K.
- ABVC BioPharma, Inc. stock issued during period, value, new issues for fiscal 2025 was $3.31M.
- ABVC BioPharma, Inc. stock issued during period, value, new issues for fiscal 2023 was $1.05M, a 71.34% decline from fiscal 2022.
- ABVC BioPharma, Inc. stock issued during period, value, new issues for fiscal 2022 was $3.66M, a 64.32% decline from fiscal 2021.
- ABVC BioPharma, Inc. stock issued during period, value, new issues for fiscal 2021 was $10.27M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $528.18K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $3.31M 10-K · filed 2026-03-03 |
| 2025-09-30 | $738.37K 10-Q/A · filed 2026-03-03 | |
| 2025-06-30 | $2.04M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $411.67K 10-Q · filed 2026-05-18 | |
| 2023-12-31 | $1.05M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $1.05M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | -$556.08K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $3.66M 10-K · filed 2024-03-13 |
| 2022-09-30 | $253.50K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.66M 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $10.27M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $6.02M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $250.00K 10-Q · filed 2021-11-15 | |
| 2020-09-30 | $2.41M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $1.92M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $267.74K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $9.12M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $5.20M 10-Q · filed 2020-11-17 | |
| 2019-06-30 | $3.00M 10-Q · filed 2020-11-17 | |
| 2019-03-31 | $694.22K 10-Q · filed 2020-11-17 | |
| 2018-12-31 | $80.00K 10-K · filed 2020-05-15 | |
| 2018-03-31 | $80.00K 10-Q · filed 2019-11-18 | |
| 2017-12-31 | $5.85M 10-K · filed 2019-04-15 | |
| 2017-09-30 | $5.85M 10-KT · filed 2018-04-13 | |
| 2016-09-30 | $3.25M 10-KT · filed 2018-04-13 | |
| 2012-09-30 | $655.00K 10-K · filed 2015-04-16 | |
| 2011-09-30 | $1.86M 10-K · filed 2015-04-15 |